Gennex Laboratories Reports Strong Sales Growth Amidst Market Challenges and Low ROE
Gennex Laboratories has recently adjusted its evaluation, reflecting strong financial performance in Q3 FY24-25. The company reported an 87.05% increase in net sales, reaching Rs 40.01 crore, and a 48.58% rise in operating profit, while maintaining a low debt-to-equity ratio of 0.07 times.
Gennex Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects its current market standing. The company has reported very positive financial performance for the third quarter of FY24-25, showcasing significant growth metrics. Notably, Gennex Laboratories achieved a remarkable 87.05% increase in net sales, with the highest quarterly figure reaching Rs 40.01 crore. The operating profit has also shown robust growth, expanding at an annual rate of 48.58%. Additionally, the company has maintained a low debt-to-equity ratio of 0.07 times, indicating a conservative approach to leverage. Despite these positive indicators, the company has faced challenges, including a return on equity (ROE) of 9.09%, which suggests room for improvement in profitability relative to shareholder funds.
While the stock has generated a return of -37.56% over the past year, its profits have risen by 81.7%. The technical indicators currently suggest a bearish trend, reflecting a complex market environment for Gennex Laboratories.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
